Neuroscience

Articles and news from the latest research reports.

92 notes

DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease
The central nervous system has a pattern of gene expression that is closely regulated with respect to functional and anatomical regions. DNA methylation is a major regulator of transcriptional activity, and aberrations in the distribution of this epigenetic mark may be involved in many neurological disorders, such as Alzheimer’s disease. Herein, we have analysed 12 distinct mouse brain regions according to their CpG 5’-end gene methylation patterns and observed their unique epigenetic landscapes. The DNA methylomes obtained from the cerebral cortex were used to identify aberrant DNA methylation changes that occurred in two mouse models of Alzheimer’s disease. We were able to translate these findings to patients with Alzheimer’s disease, identifying DNA methylation-associated silencing of three targets genes: thromboxane A2 receptor (TBXA2R), sorbin and SH3 domain containing 3 (SORBS3) and spectrin beta 4 (SPTBN4). These hypermethylation targets indicate that the cyclic AMP response element-binding protein (CREB) activation pathway and the axon initial segment could contribute to the disease.

DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease

The central nervous system has a pattern of gene expression that is closely regulated with respect to functional and anatomical regions. DNA methylation is a major regulator of transcriptional activity, and aberrations in the distribution of this epigenetic mark may be involved in many neurological disorders, such as Alzheimer’s disease. Herein, we have analysed 12 distinct mouse brain regions according to their CpG 5’-end gene methylation patterns and observed their unique epigenetic landscapes. The DNA methylomes obtained from the cerebral cortex were used to identify aberrant DNA methylation changes that occurred in two mouse models of Alzheimer’s disease. We were able to translate these findings to patients with Alzheimer’s disease, identifying DNA methylation-associated silencing of three targets genes: thromboxane A2 receptor (TBXA2R), sorbin and SH3 domain containing 3 (SORBS3) and spectrin beta 4 (SPTBN4). These hypermethylation targets indicate that the cyclic AMP response element-binding protein (CREB) activation pathway and the axon initial segment could contribute to the disease.

Filed under dna methylation alzheimer's disease epigenetics gene expression neuroscience science

  1. raskolnika reblogged this from neurosciencestuff
  2. rmalab reblogged this from neurosciencestuff
  3. ah-thenah reblogged this from neurosciencestuff
  4. marieaquamarinee reblogged this from neurosciencestuff
  5. hospitalsanjavier reblogged this from neurosciencestuff
  6. j-0112358 reblogged this from neurosciencestuff
  7. viirulentscience reblogged this from neurosciencestuff
  8. dermoosealini reblogged this from neurosciencestuff
  9. holy-shit-8 reblogged this from neurosciencestuff
  10. 41rocketpiece reblogged this from neurosciencestuff
  11. machestical reblogged this from ilungas
  12. ilungas reblogged this from neurosciencestuff
  13. melandrios reblogged this from neurosciencestuff
  14. populationpensive reblogged this from neurosciencestuff
  15. darkmichan reblogged this from neurosciencestuff
  16. lascoden reblogged this from konec0
  17. konec0 reblogged this from neurosciencestuff
  18. zombi34u reblogged this from neurosciencestuff
  19. loquequieroes reblogged this from neurosciencestuff
free counters